Home Details
| Official Symbol of Gene | S1pr1 |
| Species | Mus musculus |
| Entrez Gene ID | 29733 |
| Official Full Name | sphingosine-1-phosphate receptor 1 |
| Also known as | N/A |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSRNOG00000013683 AllianceGenome:RGD:61958 |
| Map Location | 2q41 |
| Drug | Ponesimod |
| Interaction Type | activator |
| Descent | C57Bl/6J |
| Disease | experimental autoimmune encephalomyelitis |
| Pubmed ID | 34986275 |
| Year | 2022 |
| Title | Ponesimod inhibits astrocyte-mediated neuroinflammation and protects against cingulum demyelination via S1P1 -selective modulation |
| Result | These data support the CNS activities of ponesimod through S1P1 , including protective, and likely selective, effects against demyelination in a major connection pathway of the brain, the limbic fibers of the cingulum, lesions of which have been associated with several neurologic impairments including MS fatigue. |
| Mechanism/pathway | Ponesimod is a sphingosine 1-phosphate (S1P) receptor (S1PR) modulator that was recently approved for treating relapsing forms of multiple sclerosis (MS). |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.